Merck Reports the CHMP’s Positive Opinion of Keytruda Plus Padcev to Treat Unresectable or Metastatic Urothelial Carcinoma
Shots: The CHMP has granted positive opinion to Keytruda + Padcev as a 1L treatmen...
LEO Pharma’s Anzupgo (Delgocitinib) Gains the CHMP’s Positive Opinion to Treat Moderate to Severe Chronic Hand Eczema (CHE)
Shots: The CHMP has granted positive opinion to Anzupgo cream (topical pan-JAK inh...
AbbVie’s Skyrizi (Risankizumab) Receives the EC’s Approval to Treat Moderate to Severe Active Ulcerative Colitis
Shots: The EC approved Skyrizi (induction dose: 1,200mg, IV, wks.0, 4 & 8; mai...
Sun Pharma’s Leqselvi (Deuruxolitinib) Receives the US FDA’s Approval for Treating Severe Alopecia Areata
Shots: The US FDA has granted approval to the company’s Leqselvi (8mg) table...
Pfizer Reports the EC’s Conditional Approval of Durveqtix (Fidanacogene Elaparvovec) for the Treatment of Hemophilia B
Shots: The EC has granted conditional marketing authorization to Durveqtix in seve...
ConSynance Therapeutics’ CSTI-500 Receives the US FDA’s Rare Pediatric Disease Designation to Treat Prader-Willi Syndrome
Shots: The US FDA has granted rare pediatric disease designation (RPDD) to the com...
